Zandelisib CAS No.1401436-95-0
Zandelisib CAS No.1401436-95-0
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1220 | 5mg | 380.00 | + Add to cart |
|
| R-R-1220 | 10mg | 630.00 | + Add to cart |
|
| R-R-1220 | 25mg | 1200.00 | + Add to cart |
|
|
|
||||
Product description
Zandelisib (ME-401)/CAS No.1401436-95-0 is a phosphatidylinositol 3-kinase (PI3K) inhibitor extracted from patent WO2019183226 A1, Compound Example 1. Zandelisib selectively inhibits p110δ with an IC50 of 3.5 nM. Zandelisib functions as an antineoplastic.
| Appearance | N/A |
|---|---|
| Molecular Weight | 576.68 |
| Purity | >90% |
| CAS | 1401436-95-0 |
| Formula | C31H38F2N8O |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Zandelisib CAS No.1401436-95-0
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


